Poly(ADP-ribosyl)ation polymerases: mechanism and new target of anticancer therapy. [electronic resource]
Producer: 20101105Description: 1125-36 p. digitalISSN:- 1744-8328
- Aged
- Antineoplastic Agents -- pharmacology
- Apoptosis Regulatory Proteins
- BRCA1 Protein -- deficiency
- BRCA2 Protein -- deficiency
- Breast Neoplasms -- drug therapy
- Clinical Trials, Phase I as Topic
- Clinical Trials, Phase II as Topic
- DNA Breaks, Single-Stranded
- DNA Repair
- DNA, Neoplasm -- metabolism
- Drug Delivery Systems
- Drug Resistance, Neoplasm
- Enzyme Inhibitors -- pharmacology
- Female
- Humans
- Multicenter Studies as Topic
- Neoplasm Proteins -- antagonists & inhibitors
- Ovarian Neoplasms -- drug therapy
- PTEN Phosphohydrolase -- deficiency
- Poly (ADP-Ribose) Polymerase-1
- Poly Adenosine Diphosphate Ribose -- metabolism
- Poly(ADP-ribose) Polymerase Inhibitors
- Poly(ADP-ribose) Polymerases -- physiology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.